Objectif
DESIRE will focus on epileptogenic developmental disorders EDD, i.e. early onset epilepsies whose origin is closely related to developmental brain processes. A major cause of EDD are malformations of cortical development (MCD), either macroscopic or subtle. EDD are often manifested as epileptic encephalopathies (EE), i.e. conditions in which epileptic activity itself may contribute to severe cognitive and behavioral impairments. EDD are the most frequent drug-resistant pediatric epilepsies carrying a lifelong perspective of disability and reduced quality of life. Although EDD collectively represent a major medical and socio-economic burden, their molecular diagnosis, pathogenic mechanisms (PM) and rationale treatment are poorly understood. Specific objectives of DESIRE are to advance the state of the art with respect to: (1) the genetic and epigenetic causes and PM of EDD, particularly epileptogenic MCD, to elucidate molecular networks and disrupted protein complexes and search for common bases for these apparently heterogeneous disorders. (2) the diagnostic tools (biomarkers) and protocols through the study of a unique and well-characterized cohort of children to provide standardized diagnosis for patient stratification and research across Europe. (3) treatment of EDD using randomized, multidisciplinary clinical protocols and testing preclinical strategies in experimental models to also address novel preventative strategies. The workplan spans from clinical observation, to whole exome studies, cellular and animal models and basic research, identification of biomarkers and improvement of diagnostic methods, and back to the clinical trials and assessment of innovative, targeted treatment strategies. The consortium partners have an outstanding track record in genetics, basic neurophysiology, neuropathology and clinical research. Specialized expertise will be made available by the SMEs involved to develop novel diagnostic tools for tailored treatment approaches.
Champ scientifique
Appel à propositions
FP7-HEALTH-2013-INNOVATION-1
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
50121 Florence
Italie
Voir sur la carte
Participants (27)
20133 Milano
Voir sur la carte
75654 Paris
Voir sur la carte
91054 Erlangen
Voir sur la carte
37129 Verona
Voir sur la carte
75794 Paris
Voir sur la carte
16163 Genova
Voir sur la carte
28006 Madrid
Voir sur la carte
WC2R 2LS London
Voir sur la carte
10117 Berlin
Voir sur la carte
50937 Koeln
Voir sur la carte
WC1E 6BT London
Voir sur la carte
L69 7ZX Liverpool
Voir sur la carte
Participation terminée
1050 Bruxelles / Brussel
Voir sur la carte
24118 Kiel
Voir sur la carte
3104 Melbourne
Voir sur la carte
2080 L-Imsida
Voir sur la carte
50019 Sesto Fiorentino Fi
Voir sur la carte
31021 MOGLIANO VENETO
Voir sur la carte
Participation terminée
89077 ULM
Voir sur la carte
72076 Tubingen
Voir sur la carte
2333 CH LEIDEN
Voir sur la carte
20154 Milano
Voir sur la carte
20123 Milano
Voir sur la carte
00165 Roma
Voir sur la carte
16147 Genova
Voir sur la carte
75015 PARIS 15
Voir sur la carte
49035 Angers Cedex 01
Voir sur la carte